Chronic Obstructive Pulmonary Disease (COPD) affects more than 3.5 million people (7.5% of the adult population have COPD). 16,000 patients die from it annually, i.e. 3% of deaths in France.
Diagnosis can be made by spirometry demonstrating the “obstructive ventilatory disorder”.
Smoking is by far the main risk factor in developed countries: 30% of smokers who exceed 1 packet/day for 20 years will develop COPD, i.e. 2,500,000 cases in France.
Symptoms:
- Chronic cough upon waking, “smoker’s cough”,
- Shortness of breath on effort, attributed to a lack of fitness. (Source : Pneumocourlancy).
The Spirolyser® Q13® helps to identify COPD-related disorders.
